These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 26071468)
1. Cytogenetic Variation of B-Lymphoblastic Leukemia With Intrachromosomal Amplification of Chromosome 21 (iAMP21): A Multi-Institutional Series Review. Johnson RC; Weinberg OK; Cascio MJ; Dahl GV; Mitton BA; Silverman LB; Cherry AM; Arber DA; Ohgami RS Am J Clin Pathol; 2015 Jul; 144(1):103-12. PubMed ID: 26071468 [TBL] [Abstract][Full Text] [Related]
2. Is intrachromosomal amplification of chromosome 21 (iAMP21) always intrachromosomal? Tsuchiya KD; Davis B; Gardner RA Cancer Genet; 2017 Dec; 218-219():10-14. PubMed ID: 29153092 [TBL] [Abstract][Full Text] [Related]
3. Minimal residual disease-based treatment is adequate for relapse-prone childhood acute lymphoblastic leukemia with an intrachromosomal amplification of chromosome 21: the experience of the ALL-BFM 2000 trial. Attarbaschi A; Panzer-Grümayer R; Mann G; Möricke A; König M; Mecklenbräuker A; Teigler-Schlegel A; Bradtke J; Harbott J; Göhring G; Stanulla M; Schrappe M; Zimmermann M; Haas OA; Klin Padiatr; 2014 Nov; 226(6-7):338-43. PubMed ID: 25431866 [TBL] [Abstract][Full Text] [Related]
4. Intrachromosomal amplification of chromosome 21 is associated with inferior outcomes in children with acute lymphoblastic leukemia treated in contemporary standard-risk children's oncology group studies: a report from the children's oncology group. Heerema NA; Carroll AJ; Devidas M; Loh ML; Borowitz MJ; Gastier-Foster JM; Larsen EC; Mattano LA; Maloney KW; Willman CL; Wood BL; Winick NJ; Carroll WL; Hunger SP; Raetz EA J Clin Oncol; 2013 Sep; 31(27):3397-402. PubMed ID: 23940221 [TBL] [Abstract][Full Text] [Related]
5. An international study of intrachromosomal amplification of chromosome 21 (iAMP21): cytogenetic characterization and outcome. Harrison CJ; Moorman AV; Schwab C; Carroll AJ; Raetz EA; Devidas M; Strehl S; Nebral K; Harbott J; Teigler-Schlegel A; Zimmerman M; Dastuge N; Baruchel A; Soulier J; Auclerc MF; Attarbaschi A; Mann G; Stark B; Cazzaniga G; Chilton L; Vandenberghe P; Forestier E; Haltrich I; Raimondi SC; Parihar M; Bourquin JP; Tchinda J; Haferlach C; Vora A; Hunger SP; Heerema NA; Haas OA; Leukemia; 2014 May; 28(5):1015-21. PubMed ID: 24166298 [TBL] [Abstract][Full Text] [Related]
6. Characterization of unusual iAMP21 B-lymphoblastic leukemia (iAMP21-ALL) from the Mayo Clinic and Children's Oncology Group. Koleilat A; Smadbeck JB; Zepeda-Mendoza CJ; Williamson CM; Pitel BA; Golden CL; Xu X; Greipp PT; Ketterling RP; Hoppman NL; Peterson JF; Harrison CJ; Akkari YMN; Tsuchiya KD; Shago M; Baughn LB Genes Chromosomes Cancer; 2022 Dec; 61(12):710-719. PubMed ID: 35771717 [TBL] [Abstract][Full Text] [Related]
7. Heterogeneity of Abnormal RUNX1 Leading to Clinicopathologic Variations in Childhood B-Lymphoblastic Leukemia. Knez VM; Carstens BJ; Swisshelm KL; McGranahan AN; Liang X Am J Clin Pathol; 2015 Aug; 144(2):305-14. PubMed ID: 26185316 [TBL] [Abstract][Full Text] [Related]
8. Clinicopathologic and genetic evaluation of B-lymphoblastic leukemia with intrachromosomal amplification of chromosome 21 (iAMP21) in adult patients. Zak T; Gao J; Behdad A; Mehta J; Altman JK; Ji P; Lu X; Sukhanova M Leuk Lymphoma; 2022 Dec; 63(13):3200-3207. PubMed ID: 35995457 [TBL] [Abstract][Full Text] [Related]
9. Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Munster (ALL-BFM) trials. Attarbaschi A; Mann G; Panzer-Grümayer R; Röttgers S; Steiner M; König M; Csinady E; Dworzak MN; Seidel M; Janousek D; Möricke A; Reichelt C; Harbott J; Schrappe M; Gadner H; Haas OA J Clin Oncol; 2008 Jun; 26(18):3046-50. PubMed ID: 18565891 [TBL] [Abstract][Full Text] [Related]
10. SH2B3 aberrations enriched in iAMP21 B lymphoblastic leukemia. Baughn LB; Meredith MM; Oseth L; Smolarek TA; Hirsch B Cancer Genet; 2018 Oct; 226-227():30-35. PubMed ID: 30005852 [TBL] [Abstract][Full Text] [Related]
11. Somatic homozygous loss of SH2B3, and a non-Robertsonian translocation t(15;21)(q25.3;q22.1) with NTRK3 rearrangement, in an adolescent with progenitor B-cell acute lymphoblastic leukemia with the iAMP21. Capela de Matos RR; Othman M; Ferreira GM; Monteso K; de Souza MT; Rouxinol M; Melo JB; Carreira IM; Abdelhay E; Liehr T; Ribeiro RC; Silva M Cancer Genet; 2022 Apr; 262-263():16-22. PubMed ID: 34974289 [TBL] [Abstract][Full Text] [Related]
12. Genomic characterization implicates iAMP21 as a likely primary genetic event in childhood B-cell precursor acute lymphoblastic leukemia. Rand V; Parker H; Russell LJ; Schwab C; Ensor H; Irving J; Jones L; Masic D; Minto L; Morrison H; Ryan S; Robinson H; Sinclair P; Moorman AV; Strefford JC; Harrison CJ Blood; 2011 Jun; 117(25):6848-55. PubMed ID: 21527530 [TBL] [Abstract][Full Text] [Related]
13. B-Cell Acute Lymphoblastic Leukemia with iAMP21 in a Patient with Constitutional Ring Chromosome 21. Baloda V; Aggarwal N; Rosado FG; Mackey S; Felker J; Yatsenko SA Cytogenet Genome Res; 2022; 162(5):231-236. PubMed ID: 36502796 [TBL] [Abstract][Full Text] [Related]
14. Intrachromosomal amplification of chromosome 21 (iAMP21) may arise from a breakage-fusion-bridge cycle. Robinson HM; Harrison CJ; Moorman AV; Chudoba I; Strefford JC Genes Chromosomes Cancer; 2007 Apr; 46(4):318-26. PubMed ID: 17243167 [TBL] [Abstract][Full Text] [Related]
15. Frequency and Clinical Characteristics of Intrachromosomal Amplification of Chromosome 21 in Korean Childhood B-lineage Acute Lymphoblastic Leukemia. Kim J; Lyu CJ; Shin S; Lee ST; Choi JR Ann Lab Med; 2016 Sep; 36(5):475-80. PubMed ID: 27374714 [TBL] [Abstract][Full Text] [Related]
16. Pediatric B-lymphoblastic leukemia with RUNX1 amplification: clinicopathologic study of eight cases. Reichard KK; Kang H; Robinett S Mod Pathol; 2011 Dec; 24(12):1606-11. PubMed ID: 21822204 [TBL] [Abstract][Full Text] [Related]
17. MLPA as a complementary tool for diagnosis of chromosome 21 aberrations in childhood BCP-ALL. Wrona E; Braun M; Pastorczak A; Taha J; Lejman M; Kowalczyk J; Fendler W; Młynarski W J Appl Genet; 2019 Nov; 60(3-4):347-355. PubMed ID: 31456164 [TBL] [Abstract][Full Text] [Related]
18. The genomic landscape of acute lymphoblastic leukemia with intrachromosomal amplification of chromosome 21. Gao Q; Ryan SL; Iacobucci I; Ghate PS; Cranston RE; Schwab C; Elsayed AH; Shi L; Pounds S; Lei S; Baviskar P; Pei D; Cheng C; Bashton M; Sinclair P; Bentley DR; Ross MT; Kingsbury Z; James T; Roberts KG; Devidas M; Fan Y; Chen W; Chang TC; Wu G; Carroll A; Heerema N; Valentine V; Valentine M; Yang W; Yang JJ; Moorman AV; Harrison CJ; Mullighan CG Blood; 2023 Aug; 142(8):711-723. PubMed ID: 37216686 [TBL] [Abstract][Full Text] [Related]
19. Marker chromosomes are a significant mechanism of high-level RUNX1 gene amplification in hematologic malignancies. Moosavi SA; Sanchez J; Adeyinka A Cancer Genet Cytogenet; 2009 Feb; 189(1):24-8. PubMed ID: 19167608 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of multiplex ligation dependent probe amplification (MLPA) for identification of acute lymphoblastic leukemia with an intrachromosomal amplification of chromosome 21 (iAMP21) in a Brazilian population. Fuka G; Farias-Vieira TM; Hummel L; Blunck CB; Santoro JC; Terra-Granado E; Barbosa TC; Emerenciano M; Pombo-de-Oliveira MS Mol Cytogenet; 2015; 8():35. PubMed ID: 26060508 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]